ReviewNPJ primary care respiratory medicine2026
Asthma management in pregnancy and lactation: A review of current evidence and best practice recommendations.
Review in NPJ primary care respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of Nursing Intervention Supported by Mobile Health Applications on Asthma Control, Maternal and Neonatal Outcomes Among Pregnant Women with Asthma.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review will consider current evidence regarding asthma medications during pregnancy and lactation, combined with advice regarding the importance of diagnostic certainty and best practice asthma management. Data for this review were sourced from a comprehensive search of electronic databases including PubMed, Embase, and Cochrane Library. Additional sources such as clinical practice guidelines, systematic reviews, and relevant reference lists were also consulted. Studies selected for inclusion in this review encompassed observational, case-control, and cohort studies, as well as meta-analyses and reviews published in peer-reviewed journals. Discontinuation of asthma medications during pregnancy is common and compromises asthma control, increasing the risk of adverse maternal and fetal outcomes. Breastfeeding may be unnecessarily avoided when restarting medications post-partum. There is a lack of high-quality research on asthma and allergy medications during pregnancy and lactation. Expert consensus suggests that the benefit of adequate asthma control in pregnancy outweighs the potential risks of commonly used asthma medications. Confirming the diagnosis, ensuring close monitoring and collaborating with specialists is key to safe management of asthma in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.